Objective: Analyse the outcome of pelvic exenteration for gynaecological malignancies in a tertiary referral center. Post-operative in-hospital morbidity, long-term morbidity, disease free and overall survival rates were studied. Study design: Between 1991 and 2004, 42 patients underwent an anterior, total or posterior exenteration for gynaecological malignancies. Follow-up was obtained from patient files; disease free and overall survival were calculated and prognostic factors were studied. Results: A pelvic exenteration was performed in 14 patients for primary and 28 patients for recurrent gynaecological cancers. In-hospital complications occurred in 19 patients (45%) of whom seven patients needed a reoperation (17%). Late complications occurred in 31 patients (75%); 21 reinterventions were performed (50%). Five-year disease free and overall survival was, respectively, 48 and 52%. Age, type of surgery, histology, localisation of the tumour, lateral wall involvement, completeness of resection and primary versus recurrent cancer were not identified as prognostic factors for recurrence or survival. Conclusion: Long-term survival is possible in about 50% of patients after pelvic exenteration for gynaecological cancers, but is associated with significant post-operative morbidity.

, , , ,
doi.org/10.1016/j.ejogrb.2006.07.025, hdl.handle.net/1765/36014
European Journal of Obstetrics & Gynecology and Reproductive Biology
Erasmus MC: University Medical Center Rotterdam

de Wilt, J., van Leeuwen, D., Logmans, A., Verhoef, K., Kirkels, W., Vermaas, M., & Ansink, A. (2007). Pelvic exenteration for primary and recurrent gynaecological malignancies. European Journal of Obstetrics & Gynecology and Reproductive Biology, 134(2), 243–248. doi:10.1016/j.ejogrb.2006.07.025